Summary
The effect of cimetidine, antipyrine and phenobarbitone on the pharmacokinetics of intravenous metronidazole and oral antipyrine has been examined in 7 healthy volunteers. The administration of cimetidine for 24 h before and throughout the sampling period failed to alter the total clearance of metronidazole or the rate of formation of the hydroxy metabolite, whereas the total and partial clearances of antipyrine were decreased 0.74 and 0.6–0.7-fold, respectively, Seven days of phenobarbitone or antipyrine administration increased the total clearance of metronidazole 1.51- and 1.86-fold, respectively, and the total antipyrine clearance was 1.22 or 1.46-fold increased, respectively. The rate of metronidazole hydroxylation was significantly enhanced by both enzyme inducers. The partial clearance of antipyrine to the normetabolite was significantly increased by both inducers, wheras the rate of 4-hydroxylation was significantly increased only by prior antipyrine administration. The results indicate that the hydroxylation of metronidazole is not inhibited by cimetidine, but that it is inducible by phenobarbitone or antipyrine. It is suggested that metronidazole and antipyrine are metabolized by different enzymatic pathways.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ralph ED (1983) Pharmacokinetics of metronidazole. Clin Pharmacokinet 8: 43–62
Jensen JC, Gugler R (1983) Single and multiple-dose metronidazole kinetics. Clin Pharmacol Ther 34: 481–487
Loft S, Døssing M, Poulsen HE, Sonne J, Olesen KL, Simonsen K, Andreasen PB (1986) Influence of dose and route of administration on disposition of metronidazole and its major metabolites. Eur J Clin Pharmacol 30: 467–473
Ioannides L, Somogyi A, Spicer J, Heinzow B, Tong NT, Franklin C, MacLean A (1981) Rectal administration of metronidazole provides therapeutic plasma levels in postoperative patients. New Engl J Med 305: 1569–1570
Mead PB, Schenta JJ, Ziemniak JA (1982) Possible alteration of metronidazole metabolism by phenobarbitone. New Engl J Med 307: 1490
Gupta S (1982) Phenobarbitone and metabolism of metronidazole. New Engl J Med 308: 529
Gugler R, Jensen JC (1983) Interaction between cimetidine and metronidazole. New Engl J Med 309: 1518–1519
Breimer DD (1983) Interindividual variations in drug disposition: Clinical implications and methods of investigation. Clin Pharmacokinet 8: 371–377
Stambaugh JE, Feo LG, Manthei RW (1968) The isolation and identification of the urinary metabolites of metronidazole in man. J Pharmacol Exp Ther 161: 373:-381
Teunissen MWE, Meerburg-Van Der Torren JE, Vermeulen NPE, Breimer DD (1983) Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4′-dihydroxyantipyrine. J Chromatogr 278: 367–378
Brown DR, Manno JE (1978) ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 67: 1687–1691
Gibaldi M, Perrier D (1975) Drugs and the pharmaceutical sciences Vol 1: Pharmacokinetics, Marcel Dekker, New York
Døssing M, Poulsen HE, Andreasen PB (1982) A simple method for determination of antipyrine clearance. Clin Pharmacol Ther 32: 392–396
Døssing M, Pilsgaard H, Rasmussen B, Poulsen HE (1983) Time course of phenobarbitone and cimetidine mediated changes in hepatic drug metabolism. Eur J Clin Pharmacol 25: 215–222
Pilsgaard H, Poulsen HE (1984) A one-sample method for antipyrine clearance determination in rats. Pharmacology 29: 110–116
Armitage P (1971) Statistical methods in medical research. Blackwell, Oxford
Loft S, Sonne J, Pilsgaard H, Døssing M, Poulsen HE (1986) Inhibition of antipyrine elimination by disulfiram and cimetidine: The effect of concomitant administration. Br J Clin Pharmacol 21: 75–77
Crugten J, Bochner F, Keal J, Somogyi A (1986) Selectivity of cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs. J Pharmacol Exp Ther 236: 481–487
Dey NC, Carstleden CM, Ward J, Cornhill J, McBurney A (1983) The effect of cimetidine on tolbutamide kinetics. Br J Clin Pharmacol 16: 438–440
Henauer SA, Hollister LE (1984) Cimetidine interaction with imipramine and nortriptyline. Clin Pharmacol Ther 35: 183–187
Ohnhaus EE, Park BK (1979) Measurement of urinary 6-β-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine phenobarbitone and rifampicin. Eur J Clin Pharmacol 15: 139–145
Danhof M, Verbeeek RMA, Boxteel CJ, Boeijinga JK, Breimer DD (1982) Differential effects of enzyme induction on antipyrine metabolite formation. Br J Clin Pharmacol 13: 379–386
Staiger C, Wang NS, Vries J, Weber E (1984) Untersuchungen zur Wirkung von Metronidazol auf der Phenazon-Metabolismus. Arzneimittelforsch 34: 89–91
Jensen JC, Gugler R (1985) Interaction between metronidazole and drugs eliminated by oxidative metabolism. Clin Pharmacol Ther 37: 407–410
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Loft, S., Sonne, J., Poulsen, H.E. et al. Inhibition and induction of metronidazole and antipyrine metabolism. Eur J Clin Pharmacol 32, 35–41 (1987). https://doi.org/10.1007/BF00609955
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609955